|
TOR1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.443610E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.621000E-01 |
| Normal-vs-Stage2 |
2.436300E-02 |
| Normal-vs-Stage3 |
9.187700E-02 |
| Normal-vs-Stage4 |
2.093600E-01 |
| Stage1-vs-Stage2 |
2.941600E-02 |
| Stage1-vs-Stage3 |
1.203180E-01 |
| Stage1-vs-Stage4 |
2.919800E-01 |
| Stage2-vs-Stage3 |
4.795800E-01 |
| Stage2-vs-Stage4 |
4.885800E-01 |
| Stage3-vs-Stage4 |
9.362000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.595610E-01 |
| Normal-vs-AfricanAmerican |
1.706590E-01 |
| Normal-vs-Asian |
5.780600E-01 |
| Caucasian-vs-AfricanAmerican |
6.793800E-01 |
| Caucasian-vs-Asian |
4.053400E-01 |
| AfricanAmerican-vs-Asian |
2.876400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.255600E-03 |
| Normal-vs-Female |
3.365400E-01 |
| Male-vs-Female |
1.58040000000081E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.720600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.425000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.747600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.056800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.634800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.522600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.604600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.068400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.292800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.154800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.912600E-01 |
| Normal-vs-Grade 2 |
6.739200E-01 |
| Normal-vs-Grade 3 |
4.382300E-02 |
| Normal-vs-Grade 4 |
1.645600E-01 |
| Grade 1-vs-Grade 2 |
3.037200E-01 |
| Grade 1-vs-Grade 3 |
1.108770E-01 |
| Grade 1-vs-Grade 4 |
2.340000E-01 |
| Grade 2-vs-Grade 3 |
4.436400E-02 |
| Grade 2-vs-Grade 4 |
2.270600E-01 |
| Grade 3-vs-Grade 4 |
9.064200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.140600E-01 |
| Normal-vs-ccB subtype |
4.464200E-02 |
| ccA subtype-vs-ccB subtype |
2.995200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.643600E-01 |
| Normal-vs-N1 |
9.440800E-01 |
| N0-vs-N1 |
7.001600E-01 |
|
|
